Neuroblastoma other imaging findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}}{{HL}}
{{CMG}} {{AE}}{{HL}}
==Overview==
==Overview==
Other imaging studies for neuroblastoma include nuclear medicine studies such as fludeoxyglucose-18F positron emission tomography scan (18F-FDG) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.<ref name="pmid19617326">{{cite journal| author=Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL| title=123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. | journal=J Nucl Med | year= 2009 | volume= 50 | issue= 8 | pages= 1237-43 | pmid=19617326 | doi=10.2967/jnumed.108.060467 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617326  }} </ref>
Other imaging studies for neuroblastoma include [[nuclear medicine]] studies such as fludeoxyglucose-18F positron emission tomography scan (18F-FDG) and [[metaiodobenzylguanidine]] (123I-MIBG) [[scintigraphy]].<ref name="pmid19617326">{{cite journal| author=Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL| title=123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. | journal=J Nucl Med | year= 2009 | volume= 50 | issue= 8 | pages= 1237-43 | pmid=19617326 | doi=10.2967/jnumed.108.060467 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617326  }} </ref>


==Other Imaging Findings==
==Other Imaging Findings==
===Nuclear medicine===
===Nuclear medicine===
* Nuclear medicine studies used  for diagnosis of neuroblastoma include fludeoxyglucose-18F positron emission tomography (18F-FDG PET) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.<ref name="pmid19617326">{{cite journal| author=Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL| title=123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. | journal=J Nucl Med | year= 2009 | volume= 50 | issue= 8 | pages= 1237-43 | pmid=19617326 | doi=10.2967/jnumed.108.060467 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617326  }} </ref>
* Nuclear medicine studies used  for diagnosis of neuroblastoma include fludeoxyglucose-18F positron emission tomography (18F-FDG PET) and [[metaiodobenzylguanidine]] (123I-MIBG) scintigraphy.<ref name="pmid19617326">{{cite journal| author=Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL| title=123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. | journal=J Nucl Med | year= 2009 | volume= 50 | issue= 8 | pages= 1237-43 | pmid=19617326 | doi=10.2967/jnumed.108.060467 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19617326  }} </ref>
* 18F-FDG PET scan may distinguish stage 1 and 2 neuroblastoma from other differential diagnosis.
* 18F-FDG [[PET scan]] may distinguish stage 1 and 2 neuroblastoma from other differential diagnosis.
* 123I-MIBG scintigraphy may distinguish stage 3 and 4 neuroblastoma from other differential diagnosis.
* 123I-MIBG [[scintigraphy]] may distinguish stage 3 and 4 neuroblastoma from other differential diagnosis.
* 123I-MIBG scintigraphy is superior than 18F-FDG PET scan in detecting bone marrow metastases.
* 123I-MIBG scintigraphy is superior than 18F-FDG PET scan in detecting [[bone marrow]] [[metastases]].


==References==
==References==

Revision as of 22:48, 11 October 2015

Neuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neuroblastoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neuroblastoma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neuroblastoma other imaging findings

CDC on Neuroblastoma other imaging findings

Neuroblastoma other imaging findings in the news

Blogs on Neuroblastoma other imaging findings

Directions to Hospitals Treating Neuroblastoma

Risk calculators and risk factors for Neuroblastoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Other imaging studies for neuroblastoma include nuclear medicine studies such as fludeoxyglucose-18F positron emission tomography scan (18F-FDG) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.[1]

Other Imaging Findings

Nuclear medicine

  • Nuclear medicine studies used for diagnosis of neuroblastoma include fludeoxyglucose-18F positron emission tomography (18F-FDG PET) and metaiodobenzylguanidine (123I-MIBG) scintigraphy.[1]
  • 18F-FDG PET scan may distinguish stage 1 and 2 neuroblastoma from other differential diagnosis.
  • 123I-MIBG scintigraphy may distinguish stage 3 and 4 neuroblastoma from other differential diagnosis.
  • 123I-MIBG scintigraphy is superior than 18F-FDG PET scan in detecting bone marrow metastases.

References

  1. 1.0 1.1 Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL (2009). "123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma". J Nucl Med. 50 (8): 1237–43. doi:10.2967/jnumed.108.060467. PMID 19617326.


Template:WikiDoc Sources